Destination: Cure

Deciphering the Puzzle A new round of amfAR's Countdown to a Cure initiative grants support novel cure research by Jeannie Wraight amfAR has awarded a new round...

Everyone Counts Differences in intravenous drug users may affect their response to an HIV vaccine by Jeannie Wraight Prevention strategies such as Treatment as Prevention, PrEP, syringe...

LifeGuide Trump Card Treatment and prevention are important, but an HIV cure will be the true end of AIDS by Jeannie Wraight Lately, we have been hearing a...

Cure Research with a Heart Translation inhibitors may be part of a therapeutic strategy by Jeannie Wraight To date there are over 100 documented cases of HIV...

BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....

Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...

Spectrum Analysis Broad spectrum antivirals shift the drug model paradigm by Jeannie Wraight The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...

LifeGuide Destination: Cure Checking the Map Where are we on the road to a cure? by Jeannie Wraight The past year has been wrought with disappointment on the HIV...

LifeGuide It's a Man's World Research on women & PrEP needs to keep pace by Jeannie Wraight   Whereas HIV cure and HIV prevention are two very different...

Mosaic Design APPROACH, a preventive vaccine study, seeks to address more than one clade by Jeannie Wraight Over the past thirty-plus years, strategies such as Treatment as...